Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Erica Di Cesare"'
Autor:
Erica Di Cesare, Sara Moroni, Jessica Bartoli, Michela Damizia, Maria Giubettini, Carolin Koerner, Veronica Krenn, Andrea Musacchio, Patrizia Lavia
Publikováno v:
Cells, Vol 12, Iss 3, p 372 (2023)
Conjugation with the small ubiquitin-like modifier (SUMO) modulates protein interactions and localisation. The kinase Aurora B, a key regulator of mitosis, was previously identified as a SUMOylation target in vitro and in assays with overexpressed co
Externí odkaz:
https://doaj.org/article/07b6ec6ad50e4c6e9b984a2109830bc4
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 11, Iss 4, Pp 1-12 (2020)
Cell Death and Disease, Vol 11, Iss 4, Pp 1-12 (2020)
An important component of missense mutant p53 gain-of-function (mutp53 GOF) activities is the ability of stabilized mutp53 proteins to upregulate the mevalonate pathway, providing a rationale for exploring the statin family of HMG-CoA reductase inhib
Autor:
Patrizia Lavia, Erica Di Cesare
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Autor:
Erica Di Cesare, Antonio Coluccia, Romano Silvestri, Patrizia Lavia, Annalisa Verrico, Andrea Miele, Maria Giubettini, Paola Rovella, Enrico Cundari, Valeria Famiglini, Giuseppe La Regina
Publikováno v:
Oncotarget 8 (2017): 19738–19759. doi:10.18632/oncotarget.14980
info:cnr-pdr/source/autori:Di Cesare E.; Verrico A.; Miele A.; Giubettini M.; Rovella P.; Coluccia A.; Famiglini V.; La Regina G.; Cundari E.; Silvestri R.; Lavia P./titolo:Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules/doi:10.18632%2Foncotarget.14980/rivista:Oncotarget/anno:2017/pagina_da:19738/pagina_a:19759/intervallo_pagine:19738–19759/volume:8
Oncotarget
info:cnr-pdr/source/autori:Di Cesare E.; Verrico A.; Miele A.; Giubettini M.; Rovella P.; Coluccia A.; Famiglini V.; La Regina G.; Cundari E.; Silvestri R.; Lavia P./titolo:Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules/doi:10.18632%2Foncotarget.14980/rivista:Oncotarget/anno:2017/pagina_da:19738/pagina_a:19759/intervallo_pagine:19738–19759/volume:8
Oncotarget
// Erica Di Cesare 1 , Annalisa Verrico 1 , Andrea Miele 1, 2 , Maria Giubettini 1, 3 , Paola Rovella 1 , Antonio Coluccia 4 , Valeria Famiglini 4 , Giuseppe La Regina 4 , Enrico Cundari 1 , Romano Silvestri 4 , Patrizia Lavia 1 1 Institute of Molecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::484b8534f44952d15a1abde9838fc576
http://hdl.handle.net/11573/935705
http://hdl.handle.net/11573/935705
Autor:
Jorge S. Reis-Filho, Francesco Maria Calabrese, Alan Mackay, Luca Morandi, Giovanna Cenacchi, Giuseppe Gasparre, Erica Di Cesare, Ivana Kurelac, Isabella Morra, Giovanni Tallini, Antonio Melcarne, Marcella Attimonelli, Claudio Ceccarelli, Maryou B K Lambros
Publikováno v:
Human Molecular Genetics. 22:226-238
Mitochondrial DNA (mtDNA) mutations leading to the disruption of respiratory complex I (CI) have been shown to exhibit anti-tumorigenic effects, at variance with those impairing only the function but not the assembly of the complex, which appear to c
Autor:
Feng Chen, Antonio Coluccia, Erica Di Cesare, Giulio Dondio, Ciro Mercurio, Ernest Hamel, Alessandra Soriani, Mario Varasi, Patrizia Lavia, Bruno Maresca, Marianna Nalli, Yicheng Ni, Eleonora Da Pozzo, Claudia Martini, Giuseppe La Regina, Marlein Miranda Cona, Maria Luisa Iannitto, Ruoli Bai, Barbara Costa, Amalia Porta, Sveva Pelliccia, Junjie Li, Andrea Brancale, Romano Silvestri, Ilaria Granata, Angela Santoni, Whilelmina Maria Rensen, Ettore Novellino, Valeria Famiglini, Francesco Piscitelli, Stefania Vultaggio, Alessia Reggio
Publikováno v:
Journal of medicinal chemistry (Online) 56 (2013): 123–149.
info:cnr-pdr/source/autori:La Regina G, Bai R, Rensen WM, Di Cesare E, Coluccia A, Piscitelli F, Famiglini V, Reggio A, Nalli M, Pelliccia S, Da Pozzo E, Costa B, Granata I, Porta A, Maresca B, Soriani A, Iannitto ML, Santoni A, Li J, Miranda Cona M, Chen F, Ni Y, Brancale A, Dondio G, Vultaggio S, Varasi M, Mercurio C, Martini C, Hamel E, Lavia P, Novellino E, Silvestri R/titolo:Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors./doi:/rivista:Journal of medicinal chemistry (Online)/anno:2013/pagina_da:123/pagina_a:149/intervallo_pagine:123–149/volume:56
info:cnr-pdr/source/autori:La Regina G, Bai R, Rensen WM, Di Cesare E, Coluccia A, Piscitelli F, Famiglini V, Reggio A, Nalli M, Pelliccia S, Da Pozzo E, Costa B, Granata I, Porta A, Maresca B, Soriani A, Iannitto ML, Santoni A, Li J, Miranda Cona M, Chen F, Ni Y, Brancale A, Dondio G, Vultaggio S, Varasi M, Mercurio C, Martini C, Hamel E, Lavia P, Novellino E, Silvestri R/titolo:Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors./doi:/rivista:Journal of medicinal chemistry (Online)/anno:2013/pagina_da:123/pagina_a:149/intervallo_pagine:123–149/volume:56
New arylthioindole derivatives having different cyclic substituents at position 2 of the indole were synthesized as anticancer agents. Several compounds inhibited tubulin polymerization at submicromolar concentration and inhibited cell growth at low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c53b8a1246ca046ba51a980e681ff1
http://hdl.handle.net/11588/573348
http://hdl.handle.net/11588/573348
Autor:
Patrizia Lavia, Enrico Cundari, Beate Neumann, Giulia Guarguaglini, Fabiola De Mattia, Volker Hilsenstein, Italia Anna Asteriti, Erica Di Cesare
Publikováno v:
Scopus-Elsevier
EMBL-EBI
Oncotarget 5 (2014): 6229–6242. doi:10.18632/oncotarget.2190
info:cnr-pdr/source/autori:Asteriti, Italia Anna; Di Cesare, Erica; De Mattia, Fabiola; Hilsenstein, Volker; Neumann, Beate; Cundari, Enrico; Lavia, Patrizia; Guarguaglini, Giulia/titolo:The Aurora-A inhibitor MLN8237 affects multiple mitotic processes and induces dose-dependent mitotic abnormalities and aneuploidy/doi:10.18632%2Foncotarget.2190/rivista:Oncotarget/anno:2014/pagina_da:6229/pagina_a:6242/intervallo_pagine:6229–6242/volume:5
Oncotarget
EMBL-EBI
Oncotarget 5 (2014): 6229–6242. doi:10.18632/oncotarget.2190
info:cnr-pdr/source/autori:Asteriti, Italia Anna; Di Cesare, Erica; De Mattia, Fabiola; Hilsenstein, Volker; Neumann, Beate; Cundari, Enrico; Lavia, Patrizia; Guarguaglini, Giulia/titolo:The Aurora-A inhibitor MLN8237 affects multiple mitotic processes and induces dose-dependent mitotic abnormalities and aneuploidy/doi:10.18632%2Foncotarget.2190/rivista:Oncotarget/anno:2014/pagina_da:6229/pagina_a:6242/intervallo_pagine:6229–6242/volume:5
Oncotarget
// Italia Anna Asteriti 1 , Erica Di Cesare 1 , Fabiola De Mattia 1 , Volker Hilsenstein 2 , Beate Neumann 2 , Enrico Cundari 1 , Patrizia Lavia 1 and Giulia Guarguaglini 1 1 Institute of Biology, Molecular Medicine and Nanobiotechnology (formerly In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87a041c660fbc4194c6d1c87cc653c83
http://www.scopus.com/inward/record.url?eid=2-s2.0-84906271999&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84906271999&partnerID=MN8TOARS